Solutions
Online Inquiry
Global Services. (Creative Biolabs Authorized)

Preclinical Trial-on-Chip Infrastructure & Model Development Services

Online Inquiry
Background Service What we can offer Workflow Specialty ServicesHighlights FAQs Contact

Creative Biolabs offers Preclinical Trial-on-Chip Infrastructure & Model Development Services to accelerate drug discovery and streamline preclinical evaluation. Our platform addresses long development cycles and the challenges of predictive modeling by providing customizable organ-on-chip and microphysiological systems that faithfully recapitulate human tissue and multi-organ interactions. We support end-to-end preclinical workflows, including chip design, tissue integration, functional assay development, and high-content data generation. By enabling physiologically relevant, human-relevant models, our services help reduce reliance on traditional animal studies, improve translational confidence, and provide actionable insights.

Introduction

Preclinical trial-on-chip technology provides microengineered platforms to simulate human organ-level physiology in vitro. Recent literature demonstrates that these systems improve predictive accuracy for drug response, toxicity, and pharmacokinetics compared to conventional models. By integrating multiple organ models, real-time monitoring, and advanced cellular co-cultures, these platforms accelerate preclinical evaluation and reduce reliance on animal studies.

Fig.1 Schematic of a microfluidic platform strategy for organoid integration, culture, and analysis. (OA Literature)Fig.1 Schematic of the methods for organoid integration, culture, and analysis in a chip-based device.1

Service

Creative Biolabs provides specialized infrastructure to transform your drug testing from traditional assays to high-fidelity human-relevant systems. We deliver custom-designed microphysiological environments that simulate blood flow, mechanical strain, and complex cell-cell interactions. Customers can expect precise data on drug absorption, metabolism-dependent toxicity, and organ-specific responses that traditional animal models often miss.

  • Custom Organ-on-Chip Models: Build liver, tumor, cardiac, or multi-organ microphysiological systems to mimic human biology.
  • Predictive Drug Testing: Evaluate pharmacokinetics, efficacy, and toxicity in physiologically relevant conditions before animal or clinical studies.
  • Integrated Data Analysis: Generate comprehensive reports combining functional readouts, imaging, and biomarker measurements.

Discover How We Can Help - Request a Consultation to design a chip model that meets your specific research needs.

What We Can Offer

Our service portfolio covers a wide range of human-relevant tissue models and analysis platforms:

  • Microfluidic Organ Chips: Liver-on-chip, tumor-on-chip, cardiac-on-chip for tissue-specific studies.
  • Multi-organ Integrated Systems: Combined organ models for pharmacokinetic and multi-tissue interaction analysis.
  • High-content Monitoring Platforms: Compatible with live-cell imaging, biochemical assays, and biomarker profiling.
  • Custom Model Development: Tailored microphysiological systems based on specific disease models or therapeutic targets.

Our Workflow

Required Starting Materials:

Biological samples such as primary human cells, induced pluripotent stem cells, or organoid cultures.

Project-specific compound or drug candidates for preclinical evaluation.

Desired readout metrics, including toxicity endpoints or biomarker targets.

Workflow of Preclinical Trial-on-chip Infrastructure. (Creative Biolabs Original)

Final Deliverables:

Detailed experimental reports including functional assay data and visual documentation.

Graphical summaries of pharmacokinetic, efficacy, or toxicity outcomes.

Recommendations for next-stage preclinical or clinical study design.

Specialty Services

TME Chip Customization

We design bespoke tumor microenvironment (TME) chips that bridge the gap between in vitro models and patient biology. By integrating cancer cells, stromal elements, and immune components within precise biochemical gradients, our platforms offer a high-fidelity look at tumor-immune crosstalk, therapeutic efficacy, and the nuances of drug resistance.

Learn More →

BM-on-Chip Model Customization

Our bone marrow-on-chip models are engineered to replicate the intricate hematopoietic niche. By recreating vascular structures and immune cell dynamics, we provide a biomimetic environment essential for studying hematologic malignancies, immune modulation, and the safety and performance of next-generation cell therapies.

Learn More →

Vascularized Organ-on-Chip Customization

Creative Biolabs develops vascularized models featuring fully functional, perfusable microvasculature. These systems go beyond static cultures, allowing researchers to accurately track immune cell trafficking, drug delivery efficiency, and therapeutic responses within a dynamic, physiologically relevant flow environment.

Learn More →

Preclinical Trial-on-Chip Multi-Organ Linkage System Customization

To capture systemic biological responses, we offer multi-organ linkage systems that simulate the interplay between interconnected tissues. This "Trial-on-Chip" approach provides an integrated view of pharmacokinetics (PK), systemic toxicity, and immune-oncology interactions, significantly improving preclinical predictability.

Learn More →

Preclinical Trial-on-Chip GBM Special Customization

Addressing the complexities of Glioblastoma (GBM), our specialized chips incorporate the blood-brain barrier (BBB), controlled hypoxia gradients, and immunosuppressive niches. These models are purpose-built to evaluate drug penetration and tumor invasion, providing realistic data for one of the most challenging cancers to treat.

Learn More →

Preclinical Trial-on-Chip Pancreatic "Cold Tumor" Model Customization

Our pancreatic cancer models focus on the "cold tumor" phenotype, characterized by dense desmoplastic stroma and low immune infiltration. This platform is an ideal testing ground for strategies aimed at remodeling the stroma and converting "cold" tumors into "hot" ones to enhance immunotherapy responsiveness.

Learn More →

Preclinical Trial-on-Chip Hepatocellular Carcinoma & Metastasis Solution

We provide sophisticated chips that model the progression of liver cancer from primary tumor growth to metastatic spread. By simulating liver-specific functions and vascular flow, these platforms allow for a comprehensive analysis of how tumors disseminate and how therapies can intercept them.

Learn More →

Preclinical Trial-on-Chip Pediatric Oncology Model Customization

Recognizing that pediatric cancers are biologically distinct from adult versions, we offer customization services that reflect age-specific tumor biology. These models enable safer, more ethical, and highly predictive evaluation of targeted, and immunotherapies tailored for young patients.

Learn More →

Core Benefits

  • Custom Infrastructure Development: Each system is tailored to project-specific biology, endpoints, and development stage.
  • Integrated Expertise: Combines microphysiological modeling, assay development, and data interpretation within a single workflow.
  • Scalable & Adaptable Solutions: Suitable for early screening, lead optimization, or advanced preclinical evaluation.

FAQs

Q1: What is the maximum duration for a study on your platform?

A1: Our perfusable systems are optimized for long-term culture, with many models remaining viable and functionally stable for up to 28 days or longer, making them suitable for chronic exposure studies.

Q2: How do you ensure the reproducibility of the microfluidic environment?

A2: We utilize precision engineering and automated fabrication processes. Each chip undergoes rigorous quality control for flow rate consistency and barrier integrity before testing begins.

Q3: Is it possible to model systemic effects between different organs?

A3: Yes, our multi-organoid platforms allow us to connect different organ modules via a shared circulatory loop to study systemic metabolism and toxicity.

Partner with Us

Creative Biolabs provides the cutting-edge Preclinical Trial-on-chip Infrastructure & Model Development Services required to navigate the complexities of modern drug development. By providing human-relevant, dynamic, and integrated organ models, we empower researchers to make data-driven decisions with confidence.

Our team of scientific experts is ready to help you design the optimal preclinical model for your project. Whether you need a single-organ safety screen or a complex multi-organ disease model, we provide the infrastructure and expertise to ensure success. Contact Our Team for More Information and to Discuss Your Project.

Reference

  1. Papamichail, Lito et al. "Organoids-on-a-chip: microfluidic technology enables culture of organoids with enhanced tissue function and potential for disease modeling." Frontiers in bioengineering and biotechnology vol. 13 1515340. 11 Mar. 2025. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.3389/fbioe.2025.1515340
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.